Class information for:
Level 1: GEFITINIB//EGFR MUTATION//ERLOTINIB

Basic class information
Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY 2934640
196 3       LUNG CANCER//NON SMALL CELL LUNG CANCER//THORAC SURG 53631
440 2             GEFITINIB//EGFR//EPIDERMAL GROWTH FACTOR RECEPTOR 16519
147 1                   GEFITINIB//EGFR MUTATION//ERLOTINIB 4190

Terms with highest relevance score


rank Category termType chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 GEFITINIB authKW 2350825 17% 45% 698
2 EGFR MUTATION authKW 1882595 9% 65% 385
3 ERLOTINIB authKW 1659003 13% 39% 561
4 NON SMALL CELL LUNG CANCER authKW 835512 26% 10% 1074
5 AFATINIB authKW 704328 4% 63% 149
6 EGFR authKW 609523 16% 12% 683
7 T790M authKW 581966 2% 85% 91
8 EGFR TKI authKW 573632 3% 56% 137
9 EPIDERMAL GROWTH FACTOR RECEPTOR authKW 496863 12% 13% 505
10 EPIDERMAL GROWTH FACTOR RECEPTOR MUTATION authKW 421929 2% 64% 88

Web of Science journal categories


chi_square_rank Category chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 Oncology 84554 73% 0% 3040
2 Respiratory System 22192 19% 0% 811
3 Pathology 1794 6% 0% 267
4 Pharmacology & Pharmacy 544 9% 0% 386
5 Medical Laboratory Technology 257 2% 0% 65
6 Cell Biology 222 6% 0% 246
7 Medicine, Research & Experimental 217 4% 0% 165
8 Medicine, General & Internal 76 4% 0% 159
9 Chemistry, Medicinal 39 2% 0% 72
10 Biotechnology & Applied Microbiology 18 3% 0% 105

Address terms


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 GUANGDONG LUNG CANC 188507 2% 35% 71
2 THORAC ONCOL 146200 5% 9% 209
3 LOWE THORAC ONCOL 135200 1% 31% 58
4 THORAC ONCOL SERV 119243 1% 27% 58
5 MED ONCOL 76935 17% 1% 715
6 HEMATOL ONCOL P MED 54133 1% 21% 35
7 THORAC MED ONCOL 47629 1% 23% 27
8 STATE SOUTH CHINA 47070 0% 52% 12
9 STATE SOUTHERN CHINA 35822 0% 53% 9
10 SIR YK PAU CANC 33493 0% 64% 7

Journals


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 JOURNAL OF THORACIC ONCOLOGY 222030 7% 10% 286
2 LUNG CANCER 169818 8% 7% 321
3 CLINICAL LUNG CANCER 103247 3% 13% 108
4 THORACIC CANCER 19566 1% 7% 38
5 TARGETED ONCOLOGY 14000 1% 6% 29
6 ONCOTARGETS AND THERAPY 13826 2% 3% 64
7 CLINICAL CANCER RESEARCH 12855 4% 1% 163
8 JOURNAL OF CLINICAL ONCOLOGY 8511 3% 1% 138
9 ONCOTARGET 6796 3% 1% 123
10 LANCET ONCOLOGY 5477 1% 2% 38

Author Key Words


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass LCSH search Wikipedia search
1 GEFITINIB 2350825 17% 45% 698 Search GEFITINIB Search GEFITINIB
2 EGFR MUTATION 1882595 9% 65% 385 Search EGFR+MUTATION Search EGFR+MUTATION
3 ERLOTINIB 1659003 13% 39% 561 Search ERLOTINIB Search ERLOTINIB
4 NON SMALL CELL LUNG CANCER 835512 26% 10% 1074 Search NON+SMALL+CELL+LUNG+CANCER Search NON+SMALL+CELL+LUNG+CANCER
5 AFATINIB 704328 4% 63% 149 Search AFATINIB Search AFATINIB
6 EGFR 609523 16% 12% 683 Search EGFR Search EGFR
7 T790M 581966 2% 85% 91 Search T790M Search T790M
8 EGFR TKI 573632 3% 56% 137 Search EGFR+TKI Search EGFR+TKI
9 EPIDERMAL GROWTH FACTOR RECEPTOR 496863 12% 13% 505 Search EPIDERMAL+GROWTH+FACTOR+RECEPTOR Search EPIDERMAL+GROWTH+FACTOR+RECEPTOR
10 EPIDERMAL GROWTH FACTOR RECEPTOR MUTATION 421929 2% 64% 88 Search EPIDERMAL+GROWTH+FACTOR+RECEPTOR+MUTATION Search EPIDERMAL+GROWTH+FACTOR+RECEPTOR+MUTATION

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.

Classes with closest relation at Level 1


rank cluster_id2 link
1 4265 CRIZOTINIB//ALK//ANAPLASTIC LYMPHOMA KINASE
2 27440 CODON 655//HER2 POLYMORPHISM//ILE655VAL
3 11170 4 ANILINOQUINAZOLINE//ANILINOQUINAZOLINE//COMBI MOLECULE
4 6250 NIMOTUZUMAB//CETUXIMAB//EGFR
5 826 NON SMALL CELL LUNG CANCER//VINORELBINE//GEMCITABINE
6 7485 VANDETANIB//RAMUCIRUMAB//CEDIRANIB
7 29828 REGORAFENIB//FRUQUINTINIB//N DESETHYL SUNITINIB
8 16222 TTF 1//NAPSIN A//THYROID TRANSCRIPTION FACTOR 1
9 19631 DIMERIZATION ARM//MED HEMATOL ONCOL BIOL CHEM//MOL DRUG DISCOVERY
10 1982 PANITUMUMAB//CETUXIMAB//KRAS

Go to start page